Ginsenoside R1 (5–25 mg/kg/day by gavage for 3 months), the third most abundant saponin in P. notoginseng, increased choline acetyltransferase expression and improved cognitive function in the APP/PS1 double-transgenic mouse model of AD [65]. The gene discussed is APP; the disease is Alzheimer disease.